Chemistry of lipid peroxidation products and their use as biomarkers in early detection of diseases

Journal of Oleo Science

Volumn 64, Issue 4, 2015, Pages 347-356

  Yoshida, Yasukazu ^a   Umeno, Aya ^a   Akazawa, Yoko ^a   Shichiri, Mototada ^a   Murotomi, Kazutoshi ^a   Horie, Masanori ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

HETE; HODE; Lipid peroxidation; Oxidative stress; Oxycholesterol

Indexed keywords

BIOMARKERS; FATTY ACIDS; FREE RADICALS; LIPIDS; OXIDATION; OXIDATIVE STRESS;

CLINICAL APPLICATION; HEALTHY VOLUNTEERS; HETE; HODE; LIFESTYLE-RELATED DISEASE; LIPID PEROXIDATION; OXIDATION PRODUCTS; OXYCHOLESTEROL;

LINOLEIC ACID;

BIOLOGICAL MARKER; HYDROXYOCTADECADIENOIC ACID; LINOLEIC ACID; LIPID PEROXIDE; UNSATURATED FATTY ACID;

BLOOD; DIABETES MELLITUS; EARLY DIAGNOSIS; HUMAN; LIFESTYLE; LIPID PEROXIDATION; OXIDATIVE STRESS;

BIOMARKERS; DIABETES MELLITUS; EARLY DIAGNOSIS; FATTY ACIDS, UNSATURATED; HUMANS; LIFE STYLE; LINOLEIC ACID; LIPID PEROXIDATION; LIPID PEROXIDES; OXIDATIVE STRESS;

EID: 84926203542     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.ess14281     Document Type: Review

References (59)

1. Niki, E. Do antioxidants impair signaling by reactive oxygen species and lipid oxidation products? FEBS Lstt. 586, 3767-3770 (2012).
2. Gershman, R.; Gilbert, D. L.; Nye, S. W.; Dwyer, P.; Fenn, W. O. Oxygen poisoning and X-irradiation: a mechanism in common. Science 119, 623-626 (1954).
3. Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 119, 283-300 (1956).
4. Halliwell, B.; Gutteridge, J. W. C. Free radicals in biology and medicine, fourth ed. Oxford UK: Clarendon 2007.
5. Forman, H. J.; Fukuto, J. M.; Miller, T.; Zhang, H.; Rinna, A.; Levt, S. The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch. Biochem. Biophys. 477, 183-195 (2008).
6. Poli, G.; Schaur, R. J.; Siems, W. G.; Leonarduzzi, G. 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Medic. Res. Rev. 28, 569- 631 (2008).
7. Noguchi, N. Role of oxidative stress in adaptive responses in special reference to atherosclerosis. J. Clin. Biochem. Nutr. 43, 131-138 (2008).
8. Zmijewski, J. W.; Landar, A.; Watanabe, A.; Dickinson, D. A.; Noguchi, N.; Darley-Usmar, V. M. Cell signaling by oxidized lipids and the role of reactive oxygen species in the endothelium. Biochem. Soc. Trans. 33, 1385-1389 (2005).
9. Horie, M.; Fukui, H.; Nishio, K.; Endoh, S.; Kato, H.; Fujita, K.; Miyauchi, A.; Nakamura, A.; Shichiri, M.; Ishida, N.; Kinugasa, S.; Morimoto, Y.; Niki, E.; Yoshida, Y.; Iwahashi, H. Evaluation of acute oxidative stress induced by NiO nanoparticles in vivo and in vitro. J. Occup. Health. 53, 64-74 (2011).
10. Noguchi, N.; Yamashita, H.; Hamahara, J.; Nakamura, A.; Kühn, H.; Niki, E. The specificity of lipoxygenasecatalyzed lipid peroxidation and the effects of radicalscavenging antioxidants. Biol Chem. 383, 619-626 (2002).
11. Porter, N. A.; Caldwell, S. E.; Mills, K. A. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30, 277-290 (1995).
12. Tallman, K. A.; Pratt, D. A.; Porter, N. A. Kinetic products of linoleate peroxidation: rapid beta-fragmentation of nonconjugated peroxyls. J. Am. Chem. Soc. 123, 11827-11828 (2001).
13. Niki, E. Lipid peroxidation: physiological levels and dual biological effects. Free Rad. Biol. Med. 47, 469- 484 (2009).
14. Pratt, D. A.; Tallman, K. A.; Porter, N. A. Free radical oxidation of polyunsaturated lipids: New mechanistic insights and the development of peroxyl radical clocks. Acc. Chem. Res. 44, 458-467 (2011).
15. Diczfalusy, U. Analysis of cholesterol oxidation products in biological samples. J. AOAC Int. 87, 467-473 (2004).
16. Terao, J. Cholesterol hydroperoxides and their degradation mechanism. Subcell Biochem. 77, 83-91 (2014).
17. Erickson, S. K.; Cooper, A. D.; Matsui, S. M.; Gould, R. G. 7-Ketocholesterol. Its effects on hepatic cholesterogenesis and its hepatic metabolism in vivo and in vitro. J. Biol. Chem. 252, 5186-5193 (1977).
18. Song, W.; Pierce, Jr. W. M.; Saeki, Y.; Redinger, R. N.; Prough, R. A. Endogenous 7-oxocholesterol is an enzymatic product: characterization of 7α-hydroxycholesterol dehydrogenase activity of hamster liver microsomes. Arch. Biochem. Biophys. 328, 272-282 (1996).
19. Brown, A. J.; Jessup, W. Oxysterols and atherosclerosis. Atherosclerosis 142, 1-28 (1999).
20. Porter, N. A. A perspective on free radical autoxidation: the physical organic chemistry of polyunsaturated fatty acid and sterol peroxidation. J. Org. Chem. 78, 3511-3524 (2013).
21. Xu, L.; Porter, N. A. Reactivities and products of free radical oxidation of cholestadienols. J. Am. Chem. Soc. 136, 5443-5450 (2014).
22. Nakagawa, K.; Ibusuki, D.; Suzuki, Y.; Yamashita, S.; Higuchi, O.; Oikawa, S.; Miyazawa, T. Ion-trap tandem mass spectrometric analysis of squalene monohydroperoxide isomers in sunlight-exposed human skin. J. Lipid Res. 48, 2779-2787 (2007).
23. Yamamoto, S. Mammalian lipoxygenases: molecular structures and functions. Biochim. Biophys. Acta 1128, 117-131 (1992).
24. Roberts, II L. J.; Fessel, J. P.; Davies, S. S. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathol. 15, 143-148 (2005).
25. Cracowski, J. L. Isoprostanes: an emerging role in vascular physiology and disease? J. Lipid Res. 128, 75-83 (2004).
26. Liu, W.; Yin, H.; Ogawa, Y.; Yoshida, Y.; Niki, E.; Porter, N. A. Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecanoates (: Z, E/E, E) - stereoisomer ratios. Chem. Res. Toxicol. 23, 986-995 (2010).
27. Umeno, A.; Shichiri, M.; Ishida, N.; Hashimoto, Y.; Abe, K.; Kataoka, M.; Yoshino, K.; Hagihara, Y.; Aki, N.; Funaki, M.; Asada Y.; Yoshida, Y. Singlet Oxygen Induced Products of Linoleates, 10-and 12- (Z, E) -Hydroxyoctadecadienoic Acids (HODE), Can Be Potential Biomarkers for Early Detection of Type 2 Diabetes. PloS one 8, e63542 (2013).
28. Akazawa Ogawa Y.; Shichiri, M.; Nishio, N; Yoshida, Y.; Niki E.; Hagihara Y. Singlet Oxygen-derived Products from Linoleate Activate Nrf2 Signaling in Skin Cells. Free Rad. Biol. Med. in press.
29. Murotomi, K.; Umeno, A.; Yasunaga, M.; Shichiri, M.; Ishida, N.; Abe, H.; Yoshida, Y.; Nakajima, Y. Switching from singlet-oxygen-mediated oxidation to free-radical- mediated oxidation in the pathogenesis of type 2 diabetes in model mouse. Free Radic. Res. in press.
30. Funk, C. D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875 (2001).
31. Mesaros, C.; Lee, S. H.; Blair, I. A. Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt Technol Biomed Life Sci. 877, 2736-2745 (2009).
32. Roman, R. J.; Renic, M.; Dunn, K. M.; Takeuchi, K.; Hacein-Bey, L. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm. Neurological Res. 28, 738-749 (2006).
33. Ward, N. C.; Croft, K. D.; Blacker, D.; Hankey, G. J.; Barden, A.; Mori, T. A. Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls. Clinical Sci. 121, 501-507 (2011).
34. Renic, M.; Klaus, J. A.; Omura, T.; Kawashima, N.; Onishi, M.; Miyata, N. Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 29, 629-39 (2009).
35. Seet, R. C.; Lee, C. Y.; Lim, E. C.; Tan, J. J.; Quek, A. M.; Chong, W. L.; Looi, W. F.; Huang, S. H.; Wang, H.; Chan, Y. H.; Halliwell, B. Oxidative damage in Parkinson disease: Measurement using accurate biomarkers. Free Radic. Biol. Med. 48, 560-566 (2010).
36. Schiller, J.; Süss R.; Arnhold, J.; Fuchs, B.; Lessig, J.; Müller, M.; Petkovic, M. H.; Spalteholz, ZschÖrnig M.; Arnold, K.; Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog. Lipid Res. 43, 449-488 (2004).
37. Bachi, A.; Zuccato, E.; Baraldi, M.; Fanelli, R.; Chiabrando, C. Measurements of urinary 8-epi-prostaglandin F2α, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Free Rad. Biol. Med. 20, 619-624 (1996).
38. Dalle-Donne, I.; Rossi, R.; Colombo, R.; Giustarini, D.; Milzani, A. Biomarkers of oxidative damage in human disease. Clin. Chem. 52, 601-623 (2006).
39. Yoshida, Y.; Yoshikawa, A.; Kinumi, T.; Ogawa, Y.; Saito, Y.; Ohara, K.; Yamamoto, H.; Imai, Y.; Niki, E. Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers. Neurobiol Aging 30, 174-185 (2009).
40. Yoshida, Y.; Hayakawa, M.; Habuchi, Y.; Niki, E. Evaluation of the dietary effects of coenzyme Q in vivo by the oxidative stress marker, hydroxyoctadecadienoic acid and its stereo isomer ratio. Biochim. Biophys. Acta 1760, 1558-1568 (2006).
41. Yoshida, Y.; Umeno, A.; Shichiri, M. Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo. J. Clin. Biol. Nutr. 52, 9-16 (2013).
42. Yoshida, Y.; Imai, Y., Sawai, Y.; Saito, Y.; Cao, J. F.; Fukuda, K.; Niki, E. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C. J. Gastroenterology Hepatol. 25, 107-115 (2010).
43. Montine, T.; Neely, M. D.; Quinn, J. F.; Beal, M. F.; Markesbery, W. R.; Roberts, II L. J.; Morrow, J. D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med. 33, 620-626 (2002).
44. Roberts, II L. J.; Fessel, J. P.; Davies, S. S. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathol. 15, 143-148 (2005).
45. Su, B.; Wang, X.; Nunomura, A.; Moreira, P. I.; Lee, H. G.; Perry, G.; Smith, M. A.; Zhu, X. Oxidative stress signaling in Alzheimer's disease. Curr. Alzheimer Res. 6, 525-532 (2008).
46. Gniwotta, C.; Morrow, J. D.; Roberts, II L. J.; Kühn, H. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb. Vasc. Biol. 17, 3236-3241 (1997).
47. Feldstein, A. E.; Lopez, R.; Tamimi, T. A.; Yerian, L.; Chung, Y. M.; Berk, M.; Zhang, R.; McIntyre, T. M.; Hazen, S. L. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 51, 3046- 3054 (2010).
48. Hirashima, Y.; Doshi, M.; Hayashi, N.; Endo, S.; Akazawa, Y.; Shichiri, M.; Yoshida, Y. Plasma Platelet Activating Factor-Acetylhydrolase Activity and the Levels of Free Forms of Bio-marker of Lipid Peroxidation in Cerebrospinal Fluid of Patients with Aneurysmal Subarachnoid Hemorrhage. Neurosrgery 70, 602-609 (2011).
49. Lee, S. H.; Rangiah, K.; Williams, M. V.; Wehr. A. Y.; DuBois, R. N.; Blair, I. A. Cyclooxygenase-2-mediated metabolism of arachidonic acid to 15-oxo-eicosatetraenoic acid by rat intestinal epithelial cells. Chem. Res. Toxicol. 20, 1665-1675 (2007).
50. Chen, Z. H.; Saito, Y.; Yoshida, Y.; Sekine, A.; Noguchi, N.; Niki, E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J. Biol. Chem. 280, 41921-41927 (2005).
51. Kawamoto, Y.; Nakamura, Y.; Naito, Y.; Torii, Y.; Kumagai, T.; Osawa, T.; Ohigashi, H.; Satoh, K.; Imagawa, M.; Uchida, K. Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzymes. J. Biol. Chem. 275, 11291-11299 (2000).
52. Levonen, A. L.; Dickinson, D. A.; Moellering, D. R.; Mulcahy, R. T.; Forman, H. J.; Darley-Usmar, V. M. Biphasic effects of 15-deoxy-δ12,14-prostaglandin J2 on glutathione induction and apoptosis in human endothelial cells. Arterioscler Thromb. Vasc. Biol. 21, 1846-1851 (2001).
53. Mathers, J.; Fraser, J. A.; McMahon. M.; Saunders, R. D.; Hayes, J. D.; McLellan, L. I. Antioxidant and cytoprotective responses to redox stress. Biochem. Soc. Symp. 71, 157-176 (2004).
54. Musiek, E. S.; Milne, G. L.; McLaughlin, B.; Morrow, J. D. Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity. Brain Pathol. 15, 149-158 (2005).
55. Nishimura, T.; Sekine, A.; Inoue, T.; Shibata, N.; Noguchi, N.; Arai, H. Cholesterol biosynthesis inhibition by 25-hydoxycholesterol is OSBP-independent. Genes to Cells 10, 793-801 (2005).
56. Poli, G.; Leonarduzzi, G.; Biasi, F.; Chiarpotto, E. Oxidative stress and cell signaling. Curr. Med. Chem. 11, 1163-1182 (2004).
57. Repa, J. J.; Mangelsdorf, D. J. The liver X receptor gene team: protein new players in atherosclerosis. Nature Med. 8, 1243-1248 (2002).
58. Brown, H. A.; Marnett, L. J. Introduction to lipid biochemistry, metabolism, and signaling. Chem. Rev. 111, 5817-5820 (2011).
59. Niki, E. Biomarkers of lipid peroxidation in clinical material. Biochim. Biophys. Acta 1840, 809-817 (2014).